IL2 and neoplasm: Research by Li et al. 2017 demonstrated that Lactobacillus engineered to produce IL-2 was able to reshape the TME by increasing the ratio of effector T cells to Tregs, leading to improved anti-tumor immunity in a mouse model of breast cancer.